Shanghai Pharmaceuticals Holding Co., Ltd SHPMY
$7.24
-$0.15-1.97%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -3.28% | 14.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.46% | 12.66% | |||
| Cost of Revenue | -3.00% | 13.75% | |||
| Gross Profit | 1.99% | 4.35% | |||
| SG&A Expenses | 1.55% | 3.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 43.55% | -50.04% | |||
| Total Operating Expenses | -2.53% | 12.06% | |||
| Operating Income | -0.55% | 32.12% | |||
| Income Before Tax | 34.99% | 63.03% | |||
| Income Tax Expenses | 28.74% | 9.26% | |||
| Earnings from Continuing Operations | 36.91% | 92.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 4.80% | -8.12% | |||
| Net Income | 49.63% | 151.76% | |||
| EBIT | -0.55% | 32.12% | |||
| EBITDA | 0.05% | 26.32% | |||
| EPS Basic | 49.73% | 152.51% | |||
| Normalized Basic EPS | 53.51% | 106.99% | |||
| EPS Diluted | 49.73% | 158.41% | |||
| Normalized Diluted EPS | 53.51% | 106.99% | |||
| Average Basic Shares Outstanding | -0.01% | -0.43% | |||
| Average Diluted Shares Outstanding | -0.01% | -0.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -0.68% | -0.35% | |||